Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Summit Therapeu ADR (NQ: SMMT ) 8.680 +0.390 (+4.70%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Summit Therapeu ADR < Previous 1 2 3 4 5 6 7 8 9 Next > Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 03, 2024 From Summit Therapeutics Inc. Via Business Wire 7 Top Stocks Under $10: June 2024 Edition June 24, 2024 While blue-chip stocks are great, it's also a good idea to invest in top stocks under $10 to help improve your portfolio's diversification. Via InvestorPlace 3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street June 17, 2024 These high-flying stocks could have more room to run if analysts are right. Via The Motley Fool Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million June 08, 2024 Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent... Via Talk Markets 10 Health Care Stocks With Whale Alerts In Today's Session June 07, 2024 Via Benzinga Five Below Posts Weak Q1 Results, Joins Sprinklr, Dorian LPG And Other Big Stocks Moving Lower In Thursday's Pre-Market Session June 06, 2024 Via Benzinga Why Summit Therapeutics Stock Is Trading 8% Higher Monday June 03, 2024 Based on data from a Phase III HARMONi-A clinical trial, sponsored by Akeso, that showed promising results for treating certain cancers, China granted Summit the marketing authorization. Via Benzinga Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday June 03, 2024 Via Benzinga Summit Raises $200 Million; Also Expands License Territories for Ivonescimab June 03, 2024 From Summit Therapeutics Inc. Via Business Wire Day Trading During A Slow Holiday Week June 01, 2024 We made it to the end of a holiday-shortened week. It was a slow week of day trading, but I’m happy with how it finished. Let’s break it down in today’s recap. Via Talk Markets Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership June 01, 2024 Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in... Via Talk Markets Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA June 01, 2024 From Summit Therapeutics Inc. Via Business Wire Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy May 31, 2024 From Summit Therapeutics Inc. Via Business Wire Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 31, 2024 Via Benzinga Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study May 31, 2024 Summit Therapeutics shares dropped 27.3% to $7.94 in premarket trading Friday after a 272.1% surge on Thursday. The company announced Phase 3 HARMONi-2 trial results, where ivonescimab significantly... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 31, 2024 Via Benzinga Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket May 31, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday May 31, 2024 It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers on Friday morning! Via InvestorPlace Marvell Technology Posts Weak Q1 Results, Joins MongoDB, Dell Technologies And Other Big Stocks Moving Lower In Friday's Pre-Market Session May 31, 2024 Via Benzinga Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 30, 2024 From Summit Therapeutics Inc. Via Business Wire Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China May 30, 2024 From Summit Therapeutics Inc. Via Business Wire Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 28, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 28, 2024 Via Benzinga Why Summit Therapeutics Stock Is Sinking Today May 28, 2024 Investors continue to react negatively to recent late-stage results for Summit's experimental cancer therapy. Via The Motley Fool 12 Health Care Stocks Moving In Monday's Pre-Market Session May 27, 2024 Via Benzinga Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session May 24, 2024 Via Benzinga Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket May 24, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 24, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday May 24, 2024 We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news! Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.